Tuesday, June 23, 2020 4:12:18 AM
Try all you’d like to peddle the anti-science stuff as science
Quite the opposite. I'm arguing for science.
As are the sources I referenced:-
Dr Peter Hotez is the Dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston and co-Director of the Baylor College of Medicine Coronavirus Vaccine Team.
Dr Sanjay Gupta is the Chief Medical Correspondent at CNN (for his sins..)
Kanta Subbarao is director of the World Health Organization Collaborating Centre for Reference and Research on Influenza in Melbourne, Australia.
Ralph Baric is an epidemiologist and expert in coronaviruses at the University of North Carolina at Chapel Hill.
Barney Graham is the deputy director of the Vaccine Research Center at the NIAID (no less).
Dr Paul Offitt is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children's and the co-inventor of the rotavirus vaccine.
Are you accusing all these referenced individuals of being 'anti-science'?
I didn't "come here to post this stuff".
But when I first became aware of DCVax in 2014, and began background research about immunotherapy, it opened my eyes to the biggest asset of DCVax, which is how it mobilizes the immune system in a totally harmonious and benign manner.
And that remains my view today.
And that's why I am still here.
I became aware of the toxicities associated with other immunotherapies. Most notably the hyper-progression phenomenon associated with checkpoint inhibitors.
Put simply, DCVax is, and always will be a superior immunotherapy, because it is safe. And I hope to see the response rate improve in the years to come.
How would you know about when I came here, anyway!
You have a rather strange notion of what constitutes 'spamming' and 'trolling'.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
